Passa al contenuto
Merck
  • Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures.

Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures.

Experimental neurology (2013-11-26)
Kristina A Simeone, Stephanie A Matthews, Kaeli K Samson, Timothy A Simeone
ABSTRACT

Mitochondria actively participate in neurotransmission by providing energy (ATP) and maintaining normative concentrations of reactive oxygen species (ROS) in both presynaptic and postsynaptic elements. In human and animal epilepsies, ATP-producing respiratory rates driven by mitochondrial respiratory complex (MRC) I are reduced, antioxidant systems are attenuated and oxidative damage is increased. We report that MRCI-driven respiration and functional uncoupling (an inducible antioxidant mechanism) are reduced and levels of H2O2 are elevated in mitochondria isolated from KO mice. Experimental impairment of MRCI in WT hippocampal slices via rotenone reduces paired-pulse ratios (PPRs) at mossy fiber-CA3 synapses (resembling KO PPRs), and exacerbates seizure-like events in vitro. Daily treatment with AATP [a combination therapy composed of ascorbic acid (AA), alpha-tocopherol (T), sodium pyruvate (P) designed to synergistically target mitochondrial impairments] improved mitochondrial functions, mossy fiber PPRs, and reduced seizure burden index (SBI) scores and seizure incidence in KO mice. AATP pretreatment reduced severity of KA-induced seizures resulting in 100% protection from the severe tonic-clonic seizures in WT mice. These data suggest that restoration of bioenergetic homeostasis in the brain may represent a viable anti-seizure target for temporal lobe epilepsy.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Perossido di idrogeno, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Perossido di idrogeno, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Acido L-ascorbico, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Acido L-ascorbico, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
(+)- L-ascorbato di sodio, crystalline, ≥98%
Sigma-Aldrich
Acido L-ascorbico, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Acido L-ascorbico, 99%
Sigma-Aldrich
Perossido di idrogeno, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Sigma-Aldrich
(+)- L-ascorbato di sodio, powder, BioReagent, suitable for cell culture
Supelco
Acido L-ascorbico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acido piruvico, 98%
Sigma-Aldrich
(+)- L-ascorbato di sodio, BioXtra, ≥99.0% (NT)
Millipore
Perossido di idrogeno, 3%, suitable for microbiology
Sigma-Aldrich
Acido L-ascorbico, reagent grade, crystalline
Supelco
Perossido di idrogeno, ≥30%, for trace analysis
Sigma-Aldrich
Acido L-ascorbico, ACS reagent, ≥99%
Sigma-Aldrich
Perossido di idrogeno, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 35 wt. % in H2O
Supelco
Acido L-ascorbico, analytical standard
Sigma-Aldrich
Perossido di idrogeno, purum p.a., ≥35% (RT)